Researchers have investigated a toxin–antitoxin system in tuberculosis as a therapeutic target, providing the first high-resolution details.
Browsing: Disease Area > Bacterial
Take a look behind the scenes of a recent Future Microbiology review as we ask the authors about quorum quenching and using nanoparticles as antibiotics.
Findings from a study at Portland State University suggest the severity of sepsis development and the subsequent outcome can be worsened through eating a ‘Western’ diet, high in both sugar and fat.
New research has developed a nanoparticle formulation that can knock down a key chlamydia binding protein and simultaneously induce autophagy – showing promise against this infection.
A biomimetic, micromotor vaccine formulation has shown promising results in immunizing against Staphylococcus aureus in mouse models.
Researchers have compiled the most comprehensive collection of human intestinal bacteria to date, isolating over 100 bacterial species from healthy individuals for the first time.
Take a look at this month’s industry headlines including an FDA approval for a vaccine protecting against six diseases, positive clinical trial results for bacteraemia and dengue vaccines and new funding for CRSIPR-based antimicrobials.
New research has provided evidence that basophils might play an important role in the immune response to bacterial infections, preventing the development of sepsis.
What effects can intrapartum antimicrobial use have on the neonatal microbiome development? And could they impact in long-term health?
A first for clinical trials in the US as researchers from the University of California San Diego School of Medicine get US FDA approval to use intravenously-administered bacteriophage therapy in hopes of combatting resistant bacteria.